Rivastigmine for visual hallucinations in Parkinson's disease

被引：0
作者：
Mierlo, T.
Foncke, E.
Bie, R.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
RISK;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
158
引用
收藏
页码：S66 / S67
页数：2
相关论文
共 17 条
[1]  
Bloem, 2010, ZUIDEN COMMUNICATION
[2]   Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease [J].
Burn, David ;
Emre, Murat ;
McKeith, Ian ;
De Deyn, Peter Paul ;
Aarsland, Dag ;
Hsu, Chuanchieh ;
Lane, Roger .
MOVEMENT DISORDERS, 2006, 21 (11) :1899-1907
[3]   A Recommended Scale for Cognitive Screening in Clinical Trials of Parkinson's Disease [J].
Chou, Kelvin L. ;
Amick, Melissa M. ;
Brandt, Jason ;
Camicioli, Richard ;
Frei, Karen ;
Gitelman, Darren ;
Goldman, Jennifer ;
Growdon, John ;
Hurtig, Howard I. ;
Levin, Bonnie ;
Litvan, Irene ;
Marsh, Laura ;
Simuni, Tanya ;
Troester, Alexander I. ;
Uc, Ergun Y. .
MOVEMENT DISORDERS, 2010, 25 (15) :2501-2507
[4]   Hallucinations in Parkinson disease [J].
Diederich, Nico J. ;
Fenelon, Gilles ;
Stebbins, Glenn ;
Goetz, Christopher G. .
NATURE REVIEWS NEUROLOGY, 2009, 5 (06) :331-342
[5]   Rivastigmine for dementia associated with Parkinson's disease [J].
Emre, M ;
Aarsland, D ;
Albanese, A ;
Byrne, EJ ;
Deuschl, G ;
De Deyn, PP ;
Durif, F ;
Kulisevsky, J ;
van Laar, T ;
Lees, A ;
Poewe, W ;
Robillard, A ;
Rosa, MM ;
Wolters, E ;
Quarg, P ;
Tekin, S ;
Lane, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2509-2518
[6]   Hallucinations in Parkinson's disease -: Prevalence, phenomenology and risk factors [J].
Fénelon, G ;
Mahieux, F ;
Huon, R ;
Ziégler, M .
BRAIN, 2000, 123 :733-745
[7]   Scales to assess psychosis in Parkinson's disease:: Critique and recommendations [J].
Fernandez, Hubert H. ;
Aarsland, Dag ;
Fenelon, Gilles ;
Friedman, Joseph H. ;
Marsh, Laura ;
Troster, Alexander I. ;
Poewe, Werner ;
Rascol, Olivier ;
Sampalo, Cristina ;
Stebbins, Glenn T. ;
Goetz, Christopher G. .
MOVEMENT DISORDERS, 2008, 23 (04) :484-500
[8]  
Friedman J, 1999, NEW ENGL J MED, V340, P757
[9]   The malignant course of "benign hallucinations" in Parkinson disease [J].
Goetz, CG ;
Fan, WQ ;
Leurgans, S ;
Bernard, B ;
Stebbins, GT .
ARCHIVES OF NEUROLOGY, 2006, 63 (05) :713-716
[10]   Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening [J].
Goetz, Christopher G. ;
Fan, Wenqing ;
Leurgans, Sue .
MOVEMENT DISORDERS, 2008, 23 (11) :1541-1545
12